Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Agalsidase beta
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Agalsidase beta 35mg powder for solution for infusion vials
0908010AEAAABAB
|
Agalsidase beta | Agalsidase beta | Nutrition and Blood | No data available |
|
Agalsidase beta 5mg powder for solution for infusion vials
0908010AEAAAAAA
|
Agalsidase beta | Agalsidase beta | Nutrition and Blood | No data available |
|
Fabrazyme 35mg pdr for concentrate for inf vials
0908010AEBBABAB
|
Fabrazyme | Agalsidase beta | Nutrition and Blood | No data available |
|
Fabrazyme 5mg pdr for concentrate for inf vials
0908010AEBBAAAA
|
Fabrazyme | Agalsidase beta | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.